| Kelly Svendsen, | |
|
2625 Shadelands Dr, Walnut Creek, CA 94598-2512 | |
| (925) 939-8585 | |
| Not Available |
| Full Name | Kelly Svendsen |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 5 Years |
| Location | 2625 Shadelands Dr, Walnut Creek, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063046290 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 298177 (California) | Secondary |
| 2251X0800X | Physical Therapist - Orthopedic | 298177 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Golden State Orthopedics And Spine | 8224940739 | 151 |
News Archive
When one partner in a couple is infected with HIV and the other is not, treatment with antiretroviral drugs can dramatically lower the chances of the infected partner passing along the disease to his or her mate, a new evidence review finds.
Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has today launched a major upgrade to its Data Driven Medicine Platform (Sophia DDM), offering full BRCA1/2 analysis on a single NGS (Next Generation Sequencing) run, for the first time.
In an exciting step forward to finding a cure for brain tumours, which kill more children and adults under the age of 40 than any other cancer, the national charity Brain Tumour Research brought together a group of leading brain tumour scientists and clinicians to help accelerate vital research into this devastating disease.
A researcher from The University of Texas Medical Branch at Galveston is an integral member of a collaborative group that is the first to explain the mechanisms that the Dengue virus has developed to optimize its ability to cause outbreaks as it travels across the globe to new places and revisits old ones.
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2010 (1Q10) of $1.52, ahead of management's guidance of $1.10 to $1.20. EPS for 1Q10 included earnings of approximately $0.37 per share from higher-than-anticipated favorable prior-period development of medical claims reserves as well as $0.04 per share in higher-than-projected income tax expense due to recently enacted health reform legislation. Excluding these items, 1Q10 EPS was at the top end of the company's previous guidance range.
› Verified 3 days ago
| Provider Name | Golden State Orthopedics & Spine |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1972552990 PECOS PAC ID: 8224940739 Enrollment ID: O20031103000721 |
News Archive
When one partner in a couple is infected with HIV and the other is not, treatment with antiretroviral drugs can dramatically lower the chances of the infected partner passing along the disease to his or her mate, a new evidence review finds.
Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has today launched a major upgrade to its Data Driven Medicine Platform (Sophia DDM), offering full BRCA1/2 analysis on a single NGS (Next Generation Sequencing) run, for the first time.
In an exciting step forward to finding a cure for brain tumours, which kill more children and adults under the age of 40 than any other cancer, the national charity Brain Tumour Research brought together a group of leading brain tumour scientists and clinicians to help accelerate vital research into this devastating disease.
A researcher from The University of Texas Medical Branch at Galveston is an integral member of a collaborative group that is the first to explain the mechanisms that the Dengue virus has developed to optimize its ability to cause outbreaks as it travels across the globe to new places and revisits old ones.
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2010 (1Q10) of $1.52, ahead of management's guidance of $1.10 to $1.20. EPS for 1Q10 included earnings of approximately $0.37 per share from higher-than-anticipated favorable prior-period development of medical claims reserves as well as $0.04 per share in higher-than-projected income tax expense due to recently enacted health reform legislation. Excluding these items, 1Q10 EPS was at the top end of the company's previous guidance range.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Svendsen, Po Box 31396, Walnut Creek, CA 94598-8396 Ph: (925) 939-8585 | Kelly Svendsen, 2625 Shadelands Dr, Walnut Creek, CA 94598-2512 Ph: (925) 939-8585 |
News Archive
When one partner in a couple is infected with HIV and the other is not, treatment with antiretroviral drugs can dramatically lower the chances of the infected partner passing along the disease to his or her mate, a new evidence review finds.
Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has today launched a major upgrade to its Data Driven Medicine Platform (Sophia DDM), offering full BRCA1/2 analysis on a single NGS (Next Generation Sequencing) run, for the first time.
In an exciting step forward to finding a cure for brain tumours, which kill more children and adults under the age of 40 than any other cancer, the national charity Brain Tumour Research brought together a group of leading brain tumour scientists and clinicians to help accelerate vital research into this devastating disease.
A researcher from The University of Texas Medical Branch at Galveston is an integral member of a collaborative group that is the first to explain the mechanisms that the Dengue virus has developed to optimize its ability to cause outbreaks as it travels across the globe to new places and revisits old ones.
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2010 (1Q10) of $1.52, ahead of management's guidance of $1.10 to $1.20. EPS for 1Q10 included earnings of approximately $0.37 per share from higher-than-anticipated favorable prior-period development of medical claims reserves as well as $0.04 per share in higher-than-projected income tax expense due to recently enacted health reform legislation. Excluding these items, 1Q10 EPS was at the top end of the company's previous guidance range.
› Verified 3 days ago
Joley Ann Guevara, M.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1511 Treat Blvd, #100, Walnut Creek, CA 94598 Phone: 925-949-8911 | |
Karin Hess Bright, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 320 Lennon Ln, Walnut Creek, CA 94598 Phone: 925-906-2055 Fax: 905-906-2255 | |
Mr. Scott Turtle, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2625 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-939-8585 Fax: 925-933-2709 | |
Stacey Kegg, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 454 N Wiget Ln, Walnut Creek, CA 94598 Phone: 925-482-8111 | |
Caitlin Mondt, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2625 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-256-2107 | |
Sabrina Jajeh, Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 120 La Casa Via Ste 212, Walnut Creek, CA 94598 Phone: 925-939-8710 | |
Elizabeth Anne Flannery, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Andrea Dr, Walnut Creek, CA 94596 Phone: 925-705-7872 |